These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 10215645)
1. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation. Lockhart LK; McNicol A J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity. Yang YM; Chen JZ; Wang XX; Wang SJ; Hu H; Wang HQ Eur J Pharmacol; 2008 Mar; 583(1):148-55. PubMed ID: 18291361 [TBL] [Abstract][Full Text] [Related]
3. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3. Francischetti IM; Ghazaleh FA; Reis RA; Carlini CR; Guimarães JA Arch Biochem Biophys; 1998 May; 353(2):239-50. PubMed ID: 9606958 [TBL] [Abstract][Full Text] [Related]
4. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism. Lévy-Toledano S; Grelac F; Caen JP; Maclouf J Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416 [TBL] [Abstract][Full Text] [Related]
5. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets. Vickers JD J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627 [TBL] [Abstract][Full Text] [Related]
6. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase. Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303 [TBL] [Abstract][Full Text] [Related]
7. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation. Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494 [TBL] [Abstract][Full Text] [Related]
8. In vivo activity of a phospholipase C inhibitor, 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions. Hou C; Kirchner T; Singer M; Matheis M; Argentieri D; Cavender D J Pharmacol Exp Ther; 2004 May; 309(2):697-704. PubMed ID: 14730005 [TBL] [Abstract][Full Text] [Related]
9. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore. Joseph S; Krishnamurthi S; Kakkar VV Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996 [TBL] [Abstract][Full Text] [Related]
10. U73122 blocked the cGMP-induced calcium release in sea urchin eggs. Lee SJ; Madden PJ; Shen SS Exp Cell Res; 1998 Jul; 242(1):328-40. PubMed ID: 9665830 [TBL] [Abstract][Full Text] [Related]
11. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Nakashima S; Koike T; Nozawa Y Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148 [TBL] [Abstract][Full Text] [Related]
12. Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets. Pulcinelli FM; Gresele P; Bonuglia M; Gazzaniga PP Biochem Pharmacol; 1998 Dec; 56(11):1481-4. PubMed ID: 9827580 [TBL] [Abstract][Full Text] [Related]
13. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen. Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945 [TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation. Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154 [TBL] [Abstract][Full Text] [Related]
17. Contribution of phospholipase C-beta3 phosphorylation to the rapid attenuation of opioid-activated phosphoinositide response. Strassheim D; Law PY; Loh HH Mol Pharmacol; 1998 Jun; 53(6):1047-53. PubMed ID: 9614207 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. Bleasdale JE; Thakur NR; Gremban RS; Bundy GL; Fitzpatrick FA; Smith RJ; Bunting S J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide-mediated antiplatelet activity: pivotal role of the phospholipase C gamma 2-protein kinase C-p38 MAPK cascade. Lin KH; Chang YF; Fan CY; Jayakumar T; Lee JJ; Chou DS; Hsiao G; Sheu JR Transl Res; 2010 Feb; 155(2):97-108. PubMed ID: 20129490 [TBL] [Abstract][Full Text] [Related]
20. Norepinephrine-induced changes in gene expression of phospholipase C in cardiomyocytes. Singal T; Dhalla NS; Tappia PS J Mol Cell Cardiol; 2006 Jul; 41(1):126-37. PubMed ID: 16714034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]